CJC-1295 + Ipamorelin 5 mg + 5 mgFörpackning om 10 vialer6 i lagerSpara 22 %
Utvaldpeptideintermediate6 i lager

CJC-1295 + Ipamorelin 5 mg + 5 mg

Klassisk GHRH + ghrelinmimetisk stack

CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.

Dos
5mg + 5mg / vial
Form
Lyofiliserat pulver
Förpackning
Förpackning om 10 vialer

Enbart för forskningsbruk. Denna förening säljs strikt för in vitro-forskning och laboratorieändamål och är inte avsedd för mänsklig konsumtion eller terapeutisk användning. Genom att köpa bekräftar du att du är en kvalificerad forskare och godkänner vår fullständiga ansvarsfriskrivning.

1 970 kr SEK
Spara 22 %
Förpackning om 10 vialer
Förr 2 526 kr SEK
Säljs som förpackning om 10 vialer

Endast 6 förpackningar kvar

🧪Labbverifierat
✓Testat av tredje part
⚡Snabb frakt världen över
🔒Säker kortbetalning
Översikt

Kombinerad forskningsvial som parar GHRH-analogen CJC-1295 med den selektiva ghrelinmimetikan Ipamorelin. Den mest studerade dubbelmekanism-GH-sekretagogstacken i peptidforskning.

CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.

Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.

Mekanism

CJC-1295 stöder basal GHRH-receptorsignalering medan Ipamorelin driver selektiva ghrelinreceptorpulser. Forskning tyder på synergistiska, naturalistiska GH-frisättningsmönster hos studiedeltagare.

CJC-1295: DAC vs no-DAC

CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.

FAQ för forskare

CJC-1295 + Ipamorelin — vanliga frågor

What is the CJC-1295 + Ipamorelin stack?

It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.

How does CJC-1295 differ from Ipamorelin?

CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.

Is CJC-1295 + Ipamorelin legal in Australia?

Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.

What does selective mean for Ipamorelin?

Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.

What is the typical CJC-1295 + Ipamorelin research dosage?

Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Are CJC-1295 and Ipamorelin used together?

Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.

Vidare läsning

Guider relaterade till CJC-1295 + Ipamorelin

Relaterade föreningar

Forskare utforskar också

HGHUtvaldFörpackning om 10 vialerSpara 17 %

HGH

Lyofiliserat pulver

10 IU · 4 strengths

Rekombinant humant tillväxthormon

I 2 stackar
1 164 kr SEK
Spara 17 %
Förpackning om 10 vialer
Förr 1 402 kr SEK
Visa detaljer →
TesamorelinFörpackning om 10 vialerSpara 18 %

Tesamorelin

Lyofiliserat pulver

10 mg · 3 strengths

Stabiliserad GHRH-analog

I 1 stack
3 744 kr SEK
Spara 18 %
Förpackning om 10 vialer
Förr 4 564 kr SEK
Visa detaljer →
Melanotan IIUtvaldFörpackning om 10 vialerSpara 22 %

Melanotan II

Lyofiliserat pulver

10 mg

α-MSH-analog forskningspeptid

1 182 kr SEK
Spara 22 %
Förpackning om 10 vialer
Förr 1 516 kr SEK
Visa detaljer →